Intervacc AB (IVACC) - Total Liabilities

Latest as of September 2025: Skr18.76 Million SEK ≈ $2.02 Million USD

Based on the latest financial reports, Intervacc AB (IVACC) has total liabilities worth Skr18.76 Million SEK (≈ $2.02 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Intervacc AB to evaluate the company's liquid asset resilience ratio.

Intervacc AB - Total Liabilities Trend (2013–2024)

This chart illustrates how Intervacc AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Intervacc AB.

Intervacc AB Competitors by Total Liabilities

The table below lists competitors of Intervacc AB ranked by their total liabilities.

Company	Country	Total Liabilities
Visi Media Asia Tbk JK:VIVA	Indonesia	Rp5.85 Trillion
Rockhaven Resources Ltd V:RK	Canada	CA$3.60 Million
Brand 24 SA WAR:B24	Poland	zł15.03 Million
Kishin Corporation KO:092440	Korea	₩12.86 Billion
Actinium Pharmaceuticals Inc NYSE MKT:ATNM	USA	$43.13 Million
Jiayin Group Inc NASDAQ:JFIN	USA	$4.32 Billion
GROUP PAREF INH. EO 25 F:G5I	Germany	€102.63 Million
T Scientific Co.Ltd KQ:057680	Korea	₩21.22 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Intervacc AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Intervacc AB balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	11.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intervacc AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intervacc AB (2013–2024)

The table below shows the annual total liabilities of Intervacc AB from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr24.99 Million ≈ $2.69 Million	+15.26%
2023-12-31	Skr21.68 Million ≈ $2.33 Million	+45.74%
2022-12-31	Skr14.88 Million ≈ $1.60 Million	-29.63%
2021-12-31	Skr21.14 Million ≈ $2.28 Million	+19.63%
2020-12-31	Skr17.67 Million ≈ $1.90 Million	+2.48%
2019-12-31	Skr17.25 Million ≈ $1.86 Million	+40.97%
2018-12-31	Skr12.23 Million ≈ $1.32 Million	-17.03%
2017-12-31	Skr14.74 Million ≈ $1.59 Million	-55.95%
2016-12-31	Skr33.47 Million ≈ $3.60 Million	+17.72%
2015-12-31	Skr28.44 Million ≈ $3.06 Million	-46.08%
2014-12-31	Skr52.74 Million ≈ $5.68 Million	+4143.19%
2013-12-31	Skr1.24 Million ≈ $133.76K	--

About Intervacc AB

ST:IVACC Sweden Biotechnology

Market Cap

$37.04 Million

Skr344.22 Million SEK

Market Cap Rank

#23112 Global

#435 in Sweden

Share Price

Skr1.01

Change (1 day)

+1.41%

52-Week Range

Skr0.61 - Skr1.39

All Time High

Skr89.40